2 completed. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
Follow Osilodrostat: new trials by email Literature Review of Osilodrostat trials Research Report on Osilodrostat
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety Evaluation of Osilodrostat in Cushing's Disease osilodrostat, osilodrostat Placebo - Cushing's Disease | Phase 3 | Completed | Novartis Pharmaceuticals | 73 | 2016-10-03 | 2021-11-01 |
| Safety and Efficacy of LCI699 for the Treatment of Patients With Cushing's Disease osilodrostat, LCI699 matching placebo - Cushings Disease | Phase 3 | Completed | Novartis Pharmaceuticals | 137 | 2014-10-06 | 2021-01-06 |
Adrenocortical Hyperfunction (1) · Pituitary ACTH Hypersecretion (1) · Pituitary Diseases (1)
Canada (2) · China (2) · Russia (2) · Spain (2) · Thailand (2) · Turkey (Türkiye) (2) · United States (2) · Argentina (1) · Austria (1) · Belgium (1) · Brazil (1) · Bulgaria (1) · Colombia (1) · Costa Rica (1) · France (1)
PMID 39610378, PMID 41052284, PMID 32730798, PMID 33074401, PMID 35325149, PMID 37680892, PMID 38696122